Ask AI
ProCE Banner Activity

Importance of Personalized and Multimodal Treatment: Key Insights From Recent Expert Presentations

Clinical Thought

An expert synthesizes key insights from recent presentations on the importance of a personalized and multimodal treatment approach for major depressive disorder and treatment-resistant depression. 

Released: November 12, 2024

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc. and Intra-Cellular Therapies, Inc.

AbbVie Inc.

Intra-Cellular Therapies, Inc.

Financial Disclosures

Primary Author

Lisa M. Harding, MD

Medical Director
Mood Institute
Assistant Clinical Professor of Psychiatry
Yale School of Medicine
New Haven, Connecticut

Lisa M. Harding, MD: consultant/advisor/speaker: AbbVie, DKBMED, GH Research, Janssen, Lilly, Otsuka, Takeda.